Candidate polio vaccines are safe and immunogenic

The Lancet reports on a unique polio studio by the University of Antwerp

Findings from the first-in-human study of a new polio vaccine - novel oral polio vaccine, or nOPV - reported in The Lancet this week are promising. If subsequent studies are successful, such a vaccine has the potential to supplement current eradication efforts and sustain eradication of all types of polioviruses for the long-term.

Read more


This site uses cookies and analysis tools to improve the usability of the site. More information. |